Zeon Lifesciences, an nutraceutical and herbal product manufacturer, upgrades its Paonta sahib plant enabled with AI and Industry 2.0 Automation for business growth and innovation to focus on new innovations and research advancements in India’s nutraceutical industry.
New developments have occurred at the existing plant as a result of plant advancement, such as the implementation of ZEMANEX’s new operating model (Zeon Manufacturing Excellence – The New Way of Working), the formation of a new independent vertical: Manufacturing Compliance, the implementation of the new First Line Leader (FLL) concept for better accountability and responsibility, and so on.
The firm will gain from this in terms of capacity improvement, a focused perspective on zero faults, zero waste, zero accidents, cost optimization, diverse clientele, and a greater ability to handle diverse clients and diverse demands of all dose forms. Consequently, additional jobs will be created for those with less than five years of work experience.
Suresh Garg, MD, and Founder, of Zeon Lifesciences, stated, “To tackle the upcoming challenges of industrial expansion, research & development, and innovations in the nutraceutical sector, technology-enabled innovation and consistent adoption of new technologies are required. I think this new development and the facilities at the plant will open up new opportunities for business, medical research, and innovation, as well as establish a standard for nutraceuticals in India.”
“Zeon consistently promotes innovative and translational research in an effort to revolutionize medical innovation and research in India. The main goal of this development is to conduct R&D projects that are easy to manage to study product formulation and its development in the areas of Nutraceuticals, Ayurvedic, Clinical Nutrition, Phytotherapeutics, Sports Nutrition and Cosmeceuticals,” said Dr Vivek Srivastav, Senior Vice President, Zeon Lifesciences